About Horizon Discovery
Horizon Discovery is a company based in Cambridge (United Kingdom) founded in 2007 by Alberto Bardelli was acquired by PerkinElmer in November 2020. Horizon Discovery has raised $46.29 million across 8 funding rounds from investors including PerkinElmer, Calculus Capital and University of Cambridge. Horizon Discovery has completed 2 acquisitions, including Dharmacon and Sage Research Labs. Horizon Discovery offers products and services including Pin-point™ Base Editing Reagents, CRISPR Guide RNA, siRNA, Custom Oligonucleotides, and Engineered Cell Lines. Horizon Discovery operates in a competitive market with competitors including Quanterix, Arrakis Therapeutics, NanoString, Souzhou Ribo Life Science and LGC, among others.
- Headquarter Cambridge, United Kingdom
- Founders Alberto Bardelli
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Horizon Discovery Group Limited
- Date of Incorporation 04 Mar, 2014
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$46.29 M (USD)
in 8 rounds
-
Latest Funding Round
Not available
-
Investors
PerkinElmer
& 14 more
-
Employee Count
Not available
-
Investments & Acquisitions
Dharmacon
& 1 more
-
Acquired by
PerkinElmer
(Nov 02, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Horizon Discovery
Horizon Discovery offers a comprehensive portfolio of products and services, including Pin-point™ Base Editing Reagents, CRISPR Guide RNA, siRNA, Custom Oligonucleotides, and Engineered Cell Lines.
Reagents for next-generation gene editing applications
Guides for CRISPR-Cas9 experiments in research
Small interfering RNA for RNA interference studies
Tailored DNA and RNA for specific research needs
Pre-engineered cells for functional genomics testing
People of Horizon Discovery
Unlock access to complete
Unlock access to complete
Funding Insights of Horizon Discovery
Horizon Discovery has successfully raised a total of $46.29M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Horizon Discovery
Horizon Discovery has secured backing from 15 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include PerkinElmer, Calculus Capital and University of Cambridge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm based out of USA
|
Locked | Locked | Locked | |
|
Venture capital firm investing in seed & early-stage startups
|
Locked | Locked | Locked | |
|
Stage agnostic VC firm investing globally
|
Locked | Locked | Locked |
Investor details for Horizon Discovery
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Horizon Discovery
Horizon Discovery has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Dharmacon and Sage Research Labs.
Investment portfolio details for Horizon Discovery
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Animal research models are developed and provided for scientific use.
|
Locked | Locked | 2009 | Locked | |
|
RNA oligonucleotide synthesis technology is provided for research applications.
|
Locked | Locked | 1995 | Locked |
Complete acquisition details for Horizon Discovery
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Horizon Discovery
Detailed financials for Horizon Discovery
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Horizon Discovery Comparisons
Peer comparison for Horizon Discovery
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Horizon Discovery
Horizon Discovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quanterix, Arrakis Therapeutics, NanoString, Souzhou Ribo Life Science and LGC, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Provider of tools for the analysis of RNA structures
|
|
| Locked | Locked | Locked |
Tools for translational research and molecular diagnosis are developed.
|
|
| Locked | Locked | Locked |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| Locked | Locked | Locked |
Molecular biology reagents and services are supplied to biotech industries.
|
Detailed competitors of Horizon Discovery
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Horizon Discovery
Complete news archive for Horizon Discovery
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Horizon Discovery
Horizon Discovery was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Horizon Discovery is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Terry Pizzie is the current CEO of Horizon Discovery.
Horizon Discovery is a funded company, having raised a total of $46.29M across 8 funding rounds to date.
Developer of cell lines with genetic modification using AAV gene-editing platform. The company has cell line engineering, knockout cell lines, and reporter cell lines. It also provides services in T cell activation assay, lymphocyte reaction assay, T cell-mediated tumor cell lysis assay, ADCC, and CDC assays, gene-editing for immuno-oncology, CRISPR Screening, drug combination screening, in vitro assay, and in-vivo assay.
Horizon Discovery's top competitors include NanoString, Quanterix and Arrakis Therapeutics.
Horizon Discovery offers Pin-point™ Base Editing Reagents, CRISPR Guide RNA, siRNA, Custom Oligonucleotides, and Engineered Cell Lines.
Horizon Discovery has made 2 acquisitions, including Dharmacon, and Sage Research Labs.
Horizon Discovery has 15 investors. Key investors include PerkinElmer, Calculus Capital, University of Cambridge, MVM Partners, and Draper Esprit.